An Experimental Animal Model of Postobstructive Pulmonary Hypertension

Journal of Surgical Research

Volumn 147, Issue 1, 2008, Pages 75-78

  Jungebluth, Philipp ^a   Ostertag, Helmut ^a   Macchiarini, Paolo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

chronic pulmonary hypertension; lung embolism; pulmonary artery ligation; right ventricle hypertrophy

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTERY DISEASE; ARTICLE; BLOOD GAS; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HEMODYNAMIC PARAMETERS; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SURGICAL TECHNIQUE; THORACOTOMY;

ANIMALS; DISEASE MODELS, ANIMAL; HYPERTENSION, PULMONARY; LIGATION; MALE; PULMONARY ARTERY; PULMONARY EMBOLISM; RATS; RATS, INBRED LEW; VASCULAR RESISTANCE;

EID: 43049125830     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.05.042     Document Type: Article

References (27)

1. Bresser P., Pepke-Zaba J., Jais X., et al. Medical therapies for chronic thromboembolic pulmonary hypertension: An evolving treatment paradigm. Proc Am Thorac Soc 3 (2006) 594
2. Mayer E., and Klepetko W. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3 (2006) 589
3. Piovella F., D'Armini A.M., Barone M., et al. Chronic thromboembolic pulmonary hypertension. Semin Thromb Hemost 32 (2006) 848
4. Porsolt R.D., Le P.M., and Jalfre M. Depression: A new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730
5. Fulton R.M., Hutchinson E.C., and Jones A.M. Ventricular weight in cardiac hypertrophy. Br Heart J 14 (1952) 413
6. Lang I., and Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3 (2006) 568
7. Peacock A., Simonneau G., and Rubin L. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3 (2006) 608
8. Rubin L.J., Hoeper M.M., Klepetko W., et al. Current and future management of chronic thromboembolic pulmonary hypertension: From diagnosis to treatment responses. Proc Am Thorac Soc 3 (2006) 601
9. Dartevelle P., Fadel E., Mussot S., et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 23 (2004) 637
10. Dartevelle P., Fadel E., Mussot S., et al. [Surgical treatment of chronic thromboembolic pulmonary hypertension]. Presse Med 34 (2005) 1475
11. Doyle R.L., McCrory D., Channick R.N., et al. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (2004) 63S
12. Hoeper M.M. Drug treatment of pulmonary arterial hypertension: current and future agents. Drugs 65 (2005) 1337
13. Kataoka M., Nagaya N., Satoh T., et al. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. Am J Respir Crit Care Med 172 (2005) 1575
14. Flox C.A., Escribano S.P., Tello de M.R., et al. [Transition from prostacyclin to bosentan in five patients with severe pulmonary hypertension: The switch is possible]. Rev Esp Cardiol 59 (2006) 737
15. Minai O.A., and Arroliga A.C. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan. South Med J 99 (2006) 880
16. Roman A., Gispert P., Monforte V., et al. [Long-term outcomes of treatment with bosentan in pulmonary hypertension]. Arch Bronconeumol 42 (2006) 616
17. Patterson K.C., Weissmann A., Ahmadi T., et al. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 145 (2006) 152
18. Jiang B.H., Tawara S., Abe K., et al. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol 49 (2007) 85
19. Sullivan C.C., Du L., Chu D., et al. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci USA 100 (2003) 12331
20. Chu D., Sullivan C.C., Du L., et al. A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1. Ann Thorac Surg 77 (2004) 449
21. Tamesue K., Ichiba S., Nawa S., et al. An experimental study on pumpless extracorporeal membrane oxygenation (ECMO) support in a canine model. Acta Med Okayama 60 (2006) 167
22. Yaginuma G., Suzuki Y., Togo T., et al. [A new experimental model of pulmonary hypertension in dog using an adjustable pulmonary artery band]. Nippon Kyobu Geka Gakkai Zasshi 38 (1990) 2194
23. Ulku R., Eren N.M., Cakir O., et al. [The effects of hypertonic NaCl (7.5%) in dogs with induced acute pulmonary artery obstruction]. Tuberk Toraks 51 (2003) 145
24. Faber M.J., Dalinghaus M., Lankhuizen I.M., et al. Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops. Am J Physiol Heart Circ Physiol 291 (2006) H1580
25. Cardoso P.F., Hsieh C.M., Daniel L., et al. Plasma atrial natriuretic factor concentrations in a canine model of right heart pressure overload. Clin Invest Med 14 (1991) 310
26. Kim H., Yung G.L., Marsh J.J., et al. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. Exp Lung Res 26 (2000) 287
27. Okada K., Tanaka Y., Bernstein M., et al. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol 151 (1997) 1019